Scale-Up in Pharma and CDMO Formulation

Scaling from lab to commercial in pharma and CDMO requires careful planning and documentation.

Scale-up challenges

Process parameters, equipment, and raw material variability can affect product quality at scale. Formulation and process development should be documented so scale-up is traceable.

Documentation and tech transfer

Batch records, specifications, and change control need to follow GMP. Having formulations and batch history in one platform supports tech transfer and audits.

Mix Lab AI and pharma

Mix Lab AI’s pharma CDMO vertical supports formulation development, batch tracking, and documentation for scale-up and tech transfer.